Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05247814 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborator revisedv3
  2. Start date: Feb 2022 to Jul 2022v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project will generate a prospective cohort of geriatric patients with polypharmacy which will be characterized for vulnerability profiles of adverse drug reactions.
Trial Details
NCT Number NCT05247814
Lead Sponsor RWTH Aachen University
Collaborators: B. Braun Foundation
Conditions
(from sponsor)		 Polypharmacy, Pharmacogenetics, Pharmacogenomic Testing, Drug-Related Side Effects and Adverse Reactions
Related terms Drug-Related Side Effects and Adverse Reactions, Medication Adherence
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov